EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review

Francesco Tartaglia, Giulia Antonelli, Mauro Gitto iD, Kamil Stankowski iD, Dario Donia iD, Giulio Stefanini iD, Azeem Latib iD, Antonio Colombo iD, Antonio Mangieri iD, Mauro Chiarito iD

Circulation: Cardiovascular Interventions · 2025-10 · 18 (10)

DOI: 10.1161/circinterventions.125.015298 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation: Cardiovascular Interventions, 2025-10. Verfasst von Francesco Tartaglia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy (F.T., G.A., M.G., K.S., D.D., G.S., M.C.). Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Heart Valve Prosthesis Implantation, Cardiac Catheterization. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitral regurgitation is the most common valve disease worldwide. Despite its wide success in inoperable or high-risk surgical patients, transcatheter edge-to-edge repair remains limited by some anatomic features and the non-negligible rate of significant residual regurgitation. Transcatheter mitral valve replacement has emerged as a viable alternative that promises to overcome these issues, but its development has been progressing slowly. This review aims to provide a comprehensive overview of the current state of transcatheter mitral valve replacement, including patient selection, procedural techniques, and currently available outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyMitral ValveHeart Valve Prosthesis ImplantationCardiac CatheterizationHumansTreatment OutcomeRecovery of FunctionRisk FactorsHeart Valve ProsthesisPatient SelectionHemodynamics

Stichwörter der Autor:innen

heart ventriclesmitral valvepatient selectionrisk

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy (F.T., G.A., M.G., K.S., D.D., G.S., M.C.).
  • Cardio Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano-Milan, Italy (F.T., G.A., M.G., K.S., D.D., G.S., A.C., A.M., M.C.).
  • Department of Interventional Cardiology, Montefiore Einstein Center for Heart and Vascular Care, Montefiore Medical Center, New York, NY (A.L.).

ORCID-Profile: Mauro Gitto, Kamil Stankowski, Dario Donia, Giulio Stefanini, Azeem Latib, Antonio Colombo, Antonio Mangieri, Mauro Chiarito

Zitieren

APA

Tartaglia, F., Antonelli, G., Gitto, M., Stankowski, K., Donia, D., Stefanini, G., Latib, A., Colombo, A., Mangieri, A., & Chiarito, M. (2025). TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review. Circulation: Cardiovascular Interventions, 18(10). https://doi.org/10.1161/circinterventions.125.015298

Vancouver

Tartaglia F, Antonelli G, Gitto M, Stankowski K, Donia D, Stefanini G, et al. TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review. Circulation: Cardiovascular Interventions. 2025;18(10). doi:10.1161/circinterventions.125.015298

BibTeX
@article{Tartaglia2025,
  author = {Tartaglia, Francesco and Antonelli, Giulia and Gitto, Mauro and Stankowski, Kamil and Donia, Dario and Stefanini, Giulio and Latib, Azeem and Colombo, Antonio and Mangieri, Antonio and Chiarito, Mauro},
  title = {TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {10},
  doi = {10.1161/circinterventions.125.015298}
}
Kostenlos starten →